Form 4 for KWR QUAKER CHEMICAL CORP
Accepted 2023-05-16 00:00:00 ET · period of report 2023-05-15 · accession 0001209191-23-029807 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-05-16 | 2023-05-15 | KWR | Slinkman David | SVP - CTO | M - OptEx | $147.15 | +3,683 | 5,418 | +212% | +$541.9K |
| DM | 2023-05-16 | 2023-05-15 | KWR | Slinkman David | SVP - CTO | S - Sale+OE | $204.20 | -3,683 | 4,682 | -44% | -$752.1K |
| DM | 2023-05-16 | 2023-05-15 | KWR | Slinkman David | SVP - CTO | M - OptEx | $0.00 | -3,683 | 1,213 | -75% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-15 | M | A | 606 | $178.29 | 5,288 | D | — | — | |
| 2 | Common | Common Stock | 2023-05-15 | S | D | 606 | $204.20 | 4,682 | D | — | — | |
| 3 | Common | Common Stock | 2023-05-15 | S | D | 2,341 | $204.20 | 4,682 | D | — | — | |
| 4 | Common | Common Stock | 2023-05-15 | M | A | 2,341 | $136.64 | 7,023 | D | — | — | |
| 5 | Common | Common Stock | 2023-05-15 | S | D | 736 | $204.20 | 4,682 | D | — | — | |
| 6 | Common | Common Stock | 2023-05-15 | M | A | 736 | $154.92 | 5,418 | D | — | — | |
| 7 | Derivative | Employee Stock Option (right to buy) | 2023-05-15 | M | D | 736 | $0.00 | 0 | D | $154.92 · — to 2026-02-25 | 736 Common Stock | (F2) The options for this grant vested in three annual installments: 737 shares on February 25, 2020; 737 shares on February 25, 2021; and 736 shares on February 25, 2022. |
| 8 | Derivative | Employee Stock Option (right to buy) | 2023-05-15 | M | D | 2,341 | $0.00 | 0 | D | $136.64 · — to 2027-03-30 | 2,341 Common Stock | (F3) The options for this grant vested in three annual installments: 781 shares on March 30, 2021; 780 shares on March 30, 2022; and 780 shares on March 30, 2023. |
| 9 | Derivative | Employee Stock Option (right to buy) | 2023-05-15 | M | D | 606 | $0.00 | 1,213 | D | $178.29 · — to 2029-03-16 | 606 Common Stock | (F4) The options for this grant vest in three annual installments: 606 shares on March 16, 2023; 606 shares on March 16, 2024; and 607 shares on March 16, 2025. |